Market Report · July 15, 2026
Report Feature
Narcolepsy Therapeutic Market Trends and Forecast
The future of the narcolepsy therapeutic market looks promising with opportunities in the hospitals and clinics. The global narcolepsy therapeutic market is expected to grow with a CAGR of 9% to 11% from 2023 to 2028. The major drivers for this market are growing elderly population with the need for medical attention, increasing occurrences of narcoleptic diseases, changing lifestyles, and rise in stress levels results in narcolepsy disorder.
The future of the narcolepsy therapeutic market looks promising with opportunities in the hospitals and clinics. The global narcolepsy therapeutic market is expected to grow with a CAGR of 9% to 11% from 2023 to 2028. The major drivers for this market are growing elderly population with the need for medical attention, increasing occurrences of narcoleptic diseases, changing lifestyles, and rise in stress levels results in narcolepsy disorder.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched and other details of the global narcolepsy therapeutic market report, please download the report brochure.
Narcolepsy Therapeutic Market by Segment
The study includes a forecast for the global narcolepsy therapeutic market by type, product, and region, as follows:
Narcolepsy Therapeutic Market by Type [Value ($B) Shipment Analysis from 2017 to 2028]:
- Narcolepsy with Cataplexy
- Narcolepsy without Cataplexy
- Secondary Narcolepsy
Narcolepsy Therapeutic Market by Product [Value ($B) Shipment Analysis from 2017 to 2028]:
- Central Nervous System Stimulants
- Sodium Oxybate
- Selective Serotonin Reuptake Inhibitor
- Tricyclic Antidepressants
- Others
Narcolepsy Therapeutic Market by Region [Value ($B) Shipment Analysis from 2017 to 2028]:
- North America
- Europe
- Asia Pacific
- The Rest of the World
List of Narcolepsy Therapeutic Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies narcolepsy therapeutic companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the narcolepsy therapeutic companies profiled in this report include.
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies narcolepsy therapeutic companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the narcolepsy therapeutic companies profiled in this report include.
- Jazz Pharmaceuticals
- Shionogi & Co.
- Teva Pharmaceuticals Industries
- Pfizer (Arena Pharmaceuticals, Inc.)
- Bioprojet
- Takeda Pharmaceutical Company
- Ligand Pharmaceuticals
- Graymark Healthcare.
Narcolepsy Therapeutic Market Insights
- Lucintel forecasts that narcolepsy with cataplexy will remain the largest segment over the forecast period due to increasing prevalence of cataplexy as a major symptom in patients.
- Within this market, sodium oxybate is expected to remain the fastest growing segment due to presence of favorable reimbursement policies and rising awareness levels pertaining to diagnosis & associated treatments.
- APAC will remain the fastest growing region due to increasing public awareness, high levels of disposable income, rising investments in the pharmaceutical & biotechnology industries, and supportive government efforts.
Features of the Narcolepsy Therapeutic Market
- Market Size Estimates: Narcolepsy therapeutic market size estimation in terms of value ($B)
- Trend and Forecast Analysis: Market trends (2017-2022) and forecast (2023-2028) by various segments and regions.
- Segmentation Analysis: Narcolepsy therapeutic market size by various segments, such as by type, product, and region.
- Regional Analysis: Narcolepsy therapeutic market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
- Growth Opportunities: Analysis on growth opportunities in different by type, product, and regions for the narcolepsy therapeutic market.
- Strategic Analysis: This includes M&A, new product development, and competitive landscape for the narcolepsy therapeutic market.
- Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the narcolepsy therapeutic market size?
Answer: The global narcolepsy therapeutic market is expected to reach an estimated $xx billion by 2028.
Q2. What is the growth forecast for narcolepsy therapeutic market?
Answer: The global narcolepsy therapeutic market is expected to grow with a CAGR of 9% to 11% from 2023 to 2028.
Q3. What are the major drivers influencing the growth of the narcolepsy therapeutic market?
Answer: The major drivers for this market are growing elderly population with the need for medical attention, increasing occurrences of narcoleptic diseases, changing lifestyles, and rise in stress levels results in narcolepsy disorder.
Q4. What are the major segments for narcolepsy therapeutic market?
Answer: The future of the narcolepsy therapeutic market looks promising with opportunities in the hospitals and clinics.
Q5. Who is the key narcolepsy therapeutic companies?
Answer: Some of the key narcolepsy therapeutic companies are as follows:
Q1. What is the narcolepsy therapeutic market size?
Answer: The global narcolepsy therapeutic market is expected to reach an estimated $xx billion by 2028.
Q2. What is the growth forecast for narcolepsy therapeutic market?
Answer: The global narcolepsy therapeutic market is expected to grow with a CAGR of 9% to 11% from 2023 to 2028.
Q3. What are the major drivers influencing the growth of the narcolepsy therapeutic market?
Answer: The major drivers for this market are growing elderly population with the need for medical attention, increasing occurrences of narcoleptic diseases, changing lifestyles, and rise in stress levels results in narcolepsy disorder.
Q4. What are the major segments for narcolepsy therapeutic market?
Answer: The future of the narcolepsy therapeutic market looks promising with opportunities in the hospitals and clinics.
Q5. Who is the key narcolepsy therapeutic companies?
Answer: Some of the key narcolepsy therapeutic companies are as follows:
- Jazz Pharmaceuticals
- Shionogi & Co
- Teva Pharmaceuticals Industries
- Pfizer (Arena Pharmaceuticals, Inc.)
- Bioprojet
- Takeda Pharmaceutical Company Limited
- Ligand Pharmaceuticals
- Graymark Healthcare
Q6. Which narcolepsy therapeutic segment will be the largest in future?
Answer: Lucintel forecasts that narcolepsy with cataplexy will remain the largest segment over the forecast period due to increasing prevalence of cataplexy as a major symptom in patients.
Q7. In narcolepsy therapeutic market, which region is expected to be the largest in next 5 years?
Answer: APAC will remain the fastest growing region due to increasing public awareness, high levels of disposable income, rising investments in the pharmaceutical & biotechnology industries, and supportive government efforts.
Q8. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.
Answer: Lucintel forecasts that narcolepsy with cataplexy will remain the largest segment over the forecast period due to increasing prevalence of cataplexy as a major symptom in patients.
Q7. In narcolepsy therapeutic market, which region is expected to be the largest in next 5 years?
Answer: APAC will remain the fastest growing region due to increasing public awareness, high levels of disposable income, rising investments in the pharmaceutical & biotechnology industries, and supportive government efforts.
Q8. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.
Table of Contents
1. Executive Summary
4.1 Global Narcolepsy Therapeutic Market by Region
4.2.1 North American Narcolepsy Therapeutic Market by Type: Narcolepsy With Cataplexy, Narcolepsy Without Cataplexy, and Secondary Narcolepsy
4.2.2 North American Narcolepsy Therapeutic Market by Product: Central Nervous System Stimulants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, Tricyclic Antidepressants, and Others
4.3.1 European Narcolepsy Therapeutic Market by Type: Narcolepsy With Cataplexy, Narcolepsy Without Cataplexy, and Secondary Narcolepsy
4.3.2 European Narcolepsy Therapeutic Market by Product: Central Nervous System Stimulants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, Tricyclic Antidepressants, and Others
4.4.1 APAC Narcolepsy Therapeutic Market by Type: Narcolepsy With Cataplexy, Narcolepsy Without Cataplexy, and Secondary Narcolepsy
4.4.2 APAC Narcolepsy Therapeutic Market by Product: Central Nervous System Stimulants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, Tricyclic Antidepressants, and Others
4.5.1 ROW Narcolepsy Therapeutic Market by Type: Narcolepsy With Cataplexy, Narcolepsy Without Cataplexy, and Secondary Narcolepsy
4.5.2 ROW Narcolepsy Therapeutic Market by Product: Central Nervous System Stimulants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, Tricyclic Antidepressants, and Others
Methodology
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in this market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Buy Now
Choose a license that fits your team. Instant PDF delivery.
Prices exclude taxes. Instant delivery. Custom licensing available on request.
Key Questions
- • What are some of the most promising, high-growth opportunities for the narcolepsy therapeutic market by type (narcolepsy with cataplexy, narcolepsy without cataplexy, and secondary narcolepsy), product (central nervous system stimulants, sodium oxybate, selective serotonin reuptake inhibitors, tricyclic antidepressants, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
- • Which segments will grow at a faster pace and why?
- • Which region will grow at a faster pace and why?
- • What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
- • What are the business risks and competitive threats in this market?
- • What are the emerging trends in this market and the reasons behind them?
- • What are some of the changing demands of customers in the market?
- • What are the new developments in the market? Which companies are leading these developments?
- • Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
- • What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
- • What M&A activity has occurred in the last 5 years and what has its impact been on the industry? For any questions related to narcolepsy therapeutic market or related narcolepsy therapeutic companies, narcolepsy therapeutic market size, narcolepsy therapeutic market share, narcolepsy therapeutic analysis, write Lucintel analyst at email: helpdesk@lucintel.com we will be glad to get back to you soon.
